Vasculitis

Giant Cell Arteritis Linked to Higher Incidence of Hematologic and Solid Malignancies

Publish Date August 30, 2021

Using a large nationwide electronic database, researchers assessed the association between giant cell arteritis and risk for malignancies.

2021 ACR/Vasculitis Foundation Recommendations for the Management of Giant Cell Arteritis and Takayasu Arteritis

Publish Date August 13, 2021

The American College of Rheumatology and Vasculitis Foundation released evidence-based recommendations for the management of giant cell arteritis and Takayasu arteritis.

Ultrasound Is a Useful Tool to Assess Disease Activity and Treatment Response in Giant Cell Arteritis

Publish Date July 27, 2021

Researchers assessed the sensitivity of ultrasound halo features and their association with disease activity and glucocorticoid treatment in patients with newly diagnosed giant cell arteritis.

Reduced-Dose Noninferior to High-Dose Glucocorticoid Regimen for ANCA-Associated Vasculitis Remission Induction

Publish Date June 28, 2021

Researchers compared the efficacy and adverse events of reduced-dose and high-dose glucocorticoid plus rituximab regimens for remission induction of ANCA-associated vasculitis.

Somatic UBA1 Mutations Causal for VEXAS in Patients With Relapsing Polychondritis

Publish Date June 9, 2021

Researchers determined the prevalence VEXAS in patients with relapsing polychondritis, assessed clinical, laboratory, and immunologic features, and developed a clinical algorithm to inform genetic screening for VEXAS in this population.

Association Between Steroid Therapy and Glucocorticoid Toxicity Studied in Patients With ANCA-Associated Vasculitis

Publish Date May 25, 2021

Researchers studied the association between steroid therapy and glucocorticoid toxicity in patients with ANCA-associated vasculitis.

Delays in Diagnosing Vasculitis Associated With Patient- and Health Care-Related Factors

Publish Date May 20, 2021

Researchers described diagnostic delays and the factors associated with time to diagnosis in patients with vasculitis.

Case Report: Withdrawing Immunosuppressive Therapy in RA After SARS-CoV-2 Infection and Increased Risk for Vasculitis

Publish Date May 12, 2021

Authors presented the case of a 48-year-old woman with rheumatoid arthritis, newly diagnosed microscopic polyangiitis, and a recent COVID-19 infection who stopped taking immunosuppressive therapy.

Assessing Trends and Disparities in Primary Systemic Vasculitis Mortality Rates

Publish Date May 11, 2021

Researchers aimed to estimate the mortality rates of primary systemic vasculitis and its geographic distribution, using recent population data in the US.

Trimethoprim/Sulfametoxazole Reduces Infectious Complications, But Not Relapse Risk, in ANCA-Associated Vasculitis

Publish Date April 16, 2021

Researchers assessed the role of trimethoprim/sulfametoxazole in reducing relapse rate in patients with granulomatosis with polyangiitis and infection risk in patients with ANCA-associated vasculitis.